A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Clinical trial NCT01927055 · TERMINATED

Trial details

NCT number: NCT01927055
Sponsor: Chelsea Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Neurogenic Orthostatic Hypotension Parkinson's Disease Multiple Systems Atrophy Pure Autonomic Failure Dopamine Beta Hydroxylase Deficiency

Start date: 2013-11-01
Primary completion: 2015-02-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.